Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JUAN GARZA

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1245642073
CMS profile
4218996
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$6,160.67

171 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,986.51 167
Consulting Fee $1,935.00 1
Education $239.16 3

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JUAN GARZA

NPI 1245642073 · CMS profile ID 4218996

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JUAN GARZA, NPI 1245642073, CMS profile ID 4218996. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JUAN GARZA, NPI 1245642073, CMS profile ID 4218996. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JUAN GARZA, NPI 1245642073, CMS profile ID 4218996, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 171 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1245642073?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

171 matching records · $6,160.67 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 171 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 171.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $15.2705/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878203 CMS
E.R. Squibb & Sons, L.L.C. $11.5105/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878215 CMS
Adaptive Biotechnologies Corporation $16.0705/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022979655 CMS
AstraZeneca Pharmaceuticals LP $21.0005/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011906765 CMS
Merck Sharp & Dohme LLC $25.4205/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048746939 CMS
Eisai Inc. $10.1505/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023317067 CMS
Adaptive Biotechnologies Corporation $18.3805/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022979657 CMS
Boston Scientific Corporation $29.3504/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1022005147 CMS
Eisai Inc. $22.6604/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023317065 CMS
Pharmacyclics LLC, An AbbVie Company $29.6604/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998285907 CMS
GENZYME CORPORATION $26.0804/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050047817 CMS
Novartis Pharmaceuticals Corporation $15.5104/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992209725 CMS
Celgene Corporation $27.7404/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878159 CMS
Novartis Pharmaceuticals Corporation $19.3204/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992209721 CMS
GENZYME CORPORATION $28.4104/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050047813 CMS
Janssen Biotech, Inc. $18.3304/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988391235 CMS
E.R. Squibb & Sons, L.L.C. $19.6204/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878163 CMS
E.R. Squibb & Sons, L.L.C. $20.5604/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878167 CMS
MorphoSys, US Inc. $18.5104/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060324311 CMS
E.R. Squibb & Sons, L.L.C. $12.4804/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878147 CMS
E.R. Squibb & Sons, L.L.C. $2.3704/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878151 CMS
E.R. Squibb & Sons, L.L.C. $26.0704/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878143 CMS
E.R. Squibb & Sons, L.L.C. $20.1404/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878171 CMS
Rigel Pharmaceuticals, Inc. $25.3604/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033402005 CMS
Celgene Corporation $29.2304/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878155 CMS
Pharmacosmos Therapeutics Inc. $34.6003/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046249235 CMS
Novartis Pharmaceuticals Corporation $24.1903/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992209711 CMS
Incyte Corporation $23.1103/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044555809 CMS
Novartis Pharmaceuticals Corporation $24.6703/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992209717 CMS
GENZYME CORPORATION $18.1503/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050047783 CMS
Eisai Inc. $22.0703/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023317069 CMS
Merck Sharp & Dohme LLC $25.9003/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048354965 CMS
GlaxoSmithKline, LLC. $17.8203/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003081483 CMS
Novartis Pharmaceuticals Corporation $22.6903/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992209713 CMS
E.R. Squibb & Sons, L.L.C. $22.4603/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878139 CMS
Merck Sharp & Dohme LLC $22.8403/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048354961 CMS
AstraZeneca Pharmaceuticals LP $22.9003/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014399209 CMS
AstraZeneca Pharmaceuticals LP $24.1803/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015864229 CMS
Incyte Corporation $18.0703/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044555749 CMS
PFIZER INC. $21.0703/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049384043 CMS
Eisai Inc. $20.2802/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023317063 CMS
GENZYME CORPORATION $127.8502/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050047763 CMS
E.R. Squibb & Sons, L.L.C. $21.3802/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878127 CMS
AstraZeneca Pharmaceuticals LP $23.5602/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016024451 CMS
Celgene Corporation $19.5602/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015878087 CMS
Pharmacosmos Therapeutics Inc. $37.1802/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1046249227 CMS
PFIZER INC. $23.1502/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050585527 CMS
ABBVIE INC. $30.4402/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997322557 CMS
PFIZER INC. $21.9502/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049142019 CMS
AstraZeneca Pharmaceuticals LP $123.7802/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015668213 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,297.71 20
PY2020 $798.51 23
PY2021 $5,918.95 127
PY2022 $4,144.65 188
PY2023 $6,160.67 171
PY2024 $1,057.22 46
PY2025 $2,127.21 78

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Principal investigator $138,585.60 9

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $31,626.22 12/08/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933402903
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $21,701.32 11/03/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933402055
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $1,703.00 10/13/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933401305
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $16,233.30 09/08/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933399565
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $10,867.18 08/04/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933396443
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $23,149.59 06/16/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933390277
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $20,004.99 05/19/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933387449
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $11,500.00 04/27/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933386054
Principal investigator 1 Biohaven Pharmaceutical Holding Company Ltd. $1,800.00 04/27/2022 Non-covered Recipient Entity
VIP TRIALS LLC
A Phase 4 Open-Label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention No dispute reported 06/30/2026 933386061